About Us   |   Contact Us          
HOME REPORTS TRACK RECORD DISCLAIMER
  


   LATEST REPORT
MONDAY , MAY  23th 2016 11:22 AM

Stock: CLRB Our Opinion: SHORT

HEADLINE
Cellectar Biosciences Patent Application for Phospholipid-Ether Analogs as Cancer Targeting Drug Vehicles Published by USPTO


OUR ASSESSMENT


   MISSION
Our objective is to identify stocks that are moving significantly in percentage terms, in a very short period of time. Research the fundamentals of the company to determine if the recent news justifies the gains reflected in the price. When we are confident the stock increase is not warranted, we release a report.



   DISCLAIMER
This disclaimer is to be read and fully understood before using any of our website information, following any of our social networking platforms or joining our email list. By using this website or any of our Social Network accounts you agree to the terms of this disclaimer.



   PREVIOUS REPORT
TUESDAY , MARCH  29th 2016 07:33 AM
Alert 03/29/2016 @  07:33 AM  Price: $ 6.30

Closing Price on Alert Day: $ 4.94  After 1 day: $ 4.71  After 2 days: $ 4.67




Hammer Research

About Us
Contact Us
Subscribe
Disclaimer
Site

Home
Reports
Track Record
Follow Us

Copyright © 2016 Hammer Research Corporation. All rights reserved.